Table 4.
Analysis between syndromic symptoms and risk genes
Syndromic symptoms | Families | Cases | Gene association |
---|---|---|---|
FMTC/MEN2A | 16 | 29 | RET |
Waardenburg syndrome | 12 | 22 | EDNRB/EDN3, RET/PAX3, ERBB3 |
Bardet–Biedl syndrome | 3 | 6 | – |
Special physical characteristics | 1 | 3 | EDNRB |
Respiratory symptoms | 1 | 3 | PHOX2B |
External auditory canal agenesis | 1 | 2 | ERBB3 |
Anisocoria | 1 | 2 | PHOX2B |
Multiple sclerosis | 1 | 2 | EDNRB |
Congenital central hypoventilation syndrome | 1 | 2 | PHOX2B |
Currarino syndrome | 1 | 2 | – |
Neuroblastoma | 1 | 2 | – |
Congenital heart disease | 1 | 1 | PHOX2B |
Trisomy 21 | 1 | 1 | – |
Meningocele | 1 | 1 | – |
Intellectual disability | 1 | 1 | RET/BBS |
Special physical characteristics include telecanthus, prominent nasal bridge, broad nasal bridge, tapering fingers, widely spaced nipples, low set ears, short neck, thoracic scoliosis, mild syndactyly and broad hallux. FMTC familial medullary thyroid cancer, MEN2A multiple endocrine neoplasia type 2a, RET ret proto-oncogene, EDNRB endothelin B receptor gene, EDN3 endothelin 3 gene, PAX3 paired box 3 gene, ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 gene, PHOX2B paired like homeobox 2B gene, BBS Bardet–Biedl gene. “–” no data